The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study
Open accessAbstract
ABSTRACT Background Vaccination is crucial to address the COVID-19 pandemic but vaccine hesitancy could undermine control efforts. We aimed to investigate the prevalence of COVID-19 vaccine hesitancy in the UK population, identify which population subgroups are more likely to be vaccine hesitant, and report stated reasons for vaccine hesitancy. Methods Nationally representative survey data from 12,035 participants were collected from 24th November to 1st December 2020 for wave 6 of the ‘Understanding Society’ COVID-19 web survey. Participants were asked how likely or unlikely they would be to have a vaccine if offered and their main reason for hesitancy. Cross-sectional analysis assessed prevalence of vaccine hesitancy and logistic regression models conducted. Findings Overall intention to be vaccinated was high (82% likely/very likely). Vaccine hesitancy was higher in women (21.0% vs 14.7%), younger age groups (26.5% in 16-24 year olds vs 4.5% in 75+) and less educated (18.6% no qualifications vs 13.2% degree qualified). Vaccine hesitancy was particularly high in Black (71.8%), Pakistani/Bangladeshi (42.3%), Mixed (32.4%) and non-UK/Irish White (26.4%) ethnic groups. Fully adjusted models showed gender, education and ethnicity were independently associated with vaccine hesitancy. Odds ratios for vaccine hesitancy were 12.96 (95% CI:7.34, 22.89) in the Black/Black British and 2.31 (95% CI:1.55, 3.44) in Pakistani/Bangladeshi ethnic groups (compared to White British/Irish ethnicity) and 3.24 (95%CI:1.93, 5.45) for people with no qualifications compared to degree educated. The main reason for hesitancy was fears over unknown future effects. Interpretation Older people at greatest COVID-19 mortality risk expressed the greatest willingness to be vaccinated but Black and Pakistani/Bangladeshi ethnic groups had greater vaccine hesitancy. Vaccine programmes should prioritise measures to improve uptake in specific minority ethnic groups. Funding Medical Research Council Research in context Evidence before this study We searched Embase and Medline up to November 16, 2020, using key words “vaccine hesitancy” and “COVID-19” or “SARS-CoV-2”. Vaccine hesitancy is complex but also context specific. Previous research about vaccine hesitancy relates to existing adult and childhood vaccines, with limited evidence currently available on willingness to be vaccinated for newly available COVID-19 vaccines. Existing vaccination programmes often have lower uptake among more socioeconomically disadvantaged groups. Uptake of vaccines has often varied across ethnic groups, but patterns have often varied across different vaccine programmes. Added value of this study Our study describes the sub-groups of the UK population who are more likely to be hesitant about a COVID-19 vaccine and examines possible explanations for this. We used nationally representative data from the COVID-19 survey element of the UK’s largest household panel study. We asked specifically about vaccine hesitancy in relation to a COVID-19 vaccine at a time when initial results of vaccine trials were being reported in the media. We found willingness to be vaccinated is generally high across the UK population but marked differences exist across population subgroups. Willingness to be vaccinated was greater in older age groups and in men. However, some minority ethnic groups, particularly Black/Black British and Pakistani/Bangladeshi, had high levels of vaccine hesitancy but this was not seen across all minority ethnic groups. People with lower education levels were also more likely to be vaccine hesitant. Implications of all the available evidence The current evidence base on vaccine hesitancy in relation to COVID-19 is rapidly emerging but remains limited. Polling data has also found relatively high levels of willingness to take up a COVID-19 vaccine and suggested greater risks of vaccine hesitancy among Black, Asian and Minority Ethnic (BAME) people. Our study suggests that the risk of vaccine hesitancy differs across minority ethnic groups considerably, with Black ethnic groups particularly likely to be vaccine hesitant within the UK. Some White minority ethnic groups are also more likely to be vaccine hesitant than White British/Irish people. Herd immunity may be achievable through vaccination in the UK but a focus on specific ethnic minority and socioeconomic groups is needed to ensure an equitable vaccination programme.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Grech, V., Gauci, C., & Agius, S. (2020) · Early Human Development · doi:10.1016/j.earlhumdev.2020.105213 · Cited by 117
RetractedR: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Factors associated with COVID-19-related death using OpenSAFELY
Williamson, E. J., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., Inglesby, P., et al. (2020) · Nature · doi:10.1038/s41586-020-2521-4 · Cited by 6,674
Vaccine hesitancy: Definition, scope and determinants
MacDonald, N. E. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.04.036 · Cited by 5,573
The COVID-19 pandemic and health inequalities
Bambra, C., Riordan, R., Ford, J., & Matthews, F. (2020) · Journal of Epidemiology and Community Health · doi:10.1136/jech-2020-214401 · Cited by 2,118
Vaccine hesitancy: the next challenge in the fight against COVID-19
Dror, A. A., Eisenbach, N., Taiber, S., Morozov, N. G., Mizrachi, M., Zigron, A., Srouji, S., & Sela, E. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00671-y · Cited by 1,714
Murphy, J., Vallières, F., Bentall, R. P., Shevlin, M., McBride, O., Hartman, T. K., McKay, R., Bennett, K., Mason, L., Gibson-Miller, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20226-9 · Cited by 1,283
Herd Immunity: Understanding COVID-19
Randolph, H. E., & Barreiro, L. B. (2020) · Immunity · doi:10.1016/j.immuni.2020.04.012 · Cited by 1,138
Paul, E., Steptoe, A., & Fancourt, D. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2020.100012 · Cited by 1,013
Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China
Wang, J., Jing, R., Lai, X., Zhang, H., Lyu, Y., Knoll, M. D., & Fang, H. (2020) · Vaccines · doi:10.3390/vaccines8030482 · Cited by 971
Cited by
Covid-19 vaccine hesitancy among ethnic minority groups
Razai, M. S., Osama, T., McKechnie, D. G. J., & Majeed, A. (2021) · BMJ · doi:10.1136/bmj.n513 · Cited by 481
Covid-19 vaccination hesitancy
Razai, M. S., Chaudhry, U. A. R., Doerholt, K., Bauld, L., & Majeed, A. (2021) · BMJ · doi:10.1136/bmj.n1138 · Cited by 347
Yaseen, M. O., Saif, A., Khan, T. M., Yaseen, M., Saif, A., Bukhsh, A., Shahid, M. N., Alsenani, F., Tahir, H., Ming, L. C., et al. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2031455 · Cited by 347
Vuong, Q.-H., Le, T.-T., La, V.-P., Nguyen, H. T. T., Ho, M.-T., Van Khuc, Q., & Nguyen, M.-H. (2022) · Humanities and Social Sciences Communications · doi:10.1057/s41599-022-01034-6 · Cited by 344
Vaccine Hesitancy: Contemporary Issues and Historical Background
Nuwarda, R. F., Ramzan, I., Weekes, L., & Kayser, V. (2022) · Vaccines · doi:10.3390/vaccines10101595 · Cited by 282
Metadata
- Authors
- Robertson, E., Reeve, K. S., Niedzwiedz, C. L., Moore, J., Blake, M., Green, M., Katikireddi, S. V., & Benzeval, M. J.
- Venue
- Brain, Behavior, and Immunity
- Publisher
- Elsevier BV
- Published
- 2021-05
- Volume
- 94
- Pages
- 41-50
- ISSN
- 0889-1591 (ISSN-L)
- OpenAlex
- W3135098866
- Cited by
- 690
- References
- 32
- FWCI
- 82.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study. https://app.cochat.ai/papers/10.1016/j.bbi.2021.03.008
- The paper
- Robertson, E., Reeve, K. S., Niedzwiedz, C. L., Moore, J., Blake, M., Green, M., Katikireddi, S. V., & Benzeval, M. J. (2021). Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2021.03.008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.